Litcius/Paper detail

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis

Mohammad Saeid Rezaee‐Zavareh, Yee Hui Yeo, Tielong Wang, Zhiyong Guo, Parissa Tabrizian, Stephen C. Ward, Fatma Barakat, Tarek Hassanein, Shravan Dave, Veeral Ajmera, Sherrie Bhoori, Vincenzo Mazzaferro, David M. Chascsa, Margaret C. Liu, Elizabeth S. Aby, John R. Lake, Miguel Sogbe, Bruno Sangro, Maen Abdelrahim, Abdullah Esmail, Andreas Schmiderer, Yasmina Chouik, Mark Rudolph, Davendra Sohal, Héloïse Giudicelli, Manon Allaire, Mehmet Akce, Jessica Guadagno, Clara Tow, Hatef Massoumi, Paolo De Simone, Elise Kang, Robyn D. Gartrell, Mercedes Martínez, Ricardo Paz‐Fumagalli, Beau B. Toskich, Nguyen H. Tran, Gabriela Azevedo Solino, Mariana Poltronieri Pacheco, Richard Kalman, Vatche G. Agopian, Neil Mehta, Neehar D. Parikh, Amit G. Singal, Ju Dong Yang

2024Journal of Hepatology92 citationsDOIOpen Access PDF

Topics & Concepts

Meta-analysisMedicineOncologyInternal medicineIntensive care medicineHepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersViral-associated cancers and disorders
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis | Litcius